Timothy Block
Director/Board Member chez HEPION PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
Timothy M.
Block is the founder of Hepatitis B Foundation, Baruch S.
Blumberg Institute, Hatch Biofund Management LLC, MERLIN Biotech LLC.
He is currently the President & Chief Executive Officer of Pennsylvania Biotechnology Center of Bucks County, an Independent Director at Hepion Pharmaceuticals, Inc., and a Professor-Microbiology & Immunology at Drexel University College of Medicine.
He was formerly a Director at Glycotest, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Timothy Block
| Sociétés | Poste | Début |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Board Member | 26/11/2013 |
| Hepatitis B Foundation | Founder | - |
| Drexel University College of Medicine | Corporate Officer/Principal | - |
| Pennsylvania Biotechnology Center of Bucks County | Chief Executive Officer | - |
| Baruch S. Blumberg Institute | Founder | - |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Founder | - |
Anciens postes connus de Timothy Block
| Sociétés | Poste | Fin |
|---|---|---|
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Hepatitis B Foundation | |
| Pennsylvania Biotechnology Center of Bucks County | |
| Baruch S. Blumberg Institute | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
Hatch Biofund Management LLC
Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
